Open Accessstudy of utility of Delta IGG as a prognostic marker in Guillain barre syndrome after IV immunoglobulin treatment
Author(s) -
M. S. Balaji,
M. Girish
Publication year - 2022
Publication title -
international journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns6.10406
Subject(s) - guillain barre syndrome , medicine , antibody , disease , immune system , pediatrics , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom